Covid-19 roundup: Ques­tions re­main on US sup­plies of Pfiz­er, Mer­ck pills as UK ramps up; Is­rael to go for a fourth dose for those over 60

As the FDA is poised to au­tho­rize the new Pfiz­er and Mer­ck pills to treat those with Covid-19 who haven’t been hos­pi­tal­ized, Bloomberg

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.